2015 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 9
TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1
with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Landline And Cell Phone Combined Sample, United States, 2015
State/Territory |
Current |
Active |
Sample
size±
|
% |
SE§
|
95% CI†
|
Sample
size |
% |
SE |
95% CI |
Connecticut |
347 |
32.6 |
3.5 |
(25.7 – 39.5) |
382 |
31.4 |
3.3 |
(24.9 – 37.9) |
Florida |
212 |
35.0 |
4.6 |
(26.0 – 44.0) |
236 |
31.9 |
4.2 |
(23.7 – 40.1) |
Georgia |
175 |
22.9 |
4.3 |
(14.5 – 31.3) |
177 |
23.8 |
4.4 |
(15.2 – 32.4) |
Hawaii |
162 |
34.6 |
5.6 |
(23.6 – 45.6) |
191 |
27.7 |
4.6 |
(18.7 – 36.7) |
Indiana |
206 |
31.1 |
5.5 |
(20.3 – 41.9) |
220 |
31.8 |
5.3 |
(21.4 – 42.2) |
Iowa |
181 |
38.4 |
5.4 |
(27.8 – 49.0) |
194 |
36.9 |
5.1 |
(26.9 – 46.9) |
Kansas |
589 |
30.2 |
2.3 |
(25.7 – 34.7) |
608 |
29.9 |
2.3 |
(25.4 – 34.4) |
Maine |
263 |
34.2 |
4.0 |
(26.4 – 42.0) |
274 |
33.5 |
3.9 |
(25.9 – 41.1) |
Massachusetts |
252 |
39.1 |
4.6 |
(30.1 – 48.1) |
278 |
35.4 |
4.1 |
(27.4 – 43.4) |
Michigan |
408 |
37.4 |
3.0 |
(31.5 – 43.3) |
439 |
34.8 |
2.9 |
(29.1 – 40.5) |
Minnesota |
604 |
31.7 |
2.4 |
(27.0 – 36.4) |
629 |
30.9 |
2.4 |
(26.2 – 35.6) |
Mississippi |
169 |
25.5 |
4.8 |
(16.1 – 34.9) |
174 |
24.3 |
4.9 |
(14.7 – 33.9) |
Missouri |
198 |
48.7 |
5.8 |
(37.3 – 60.1) |
206 |
47.7 |
5.7 |
(36.5 – 58.9) |
Montana |
142 |
38.9 |
6.5 |
(26.2 – 51.6) |
149 |
37.2 |
6.2 |
(25.0 – 49.4) |
Nebraska |
468 |
29.6 |
3.2 |
(23.3 – 35.9) |
500 |
26.8 |
2.9 |
(21.1 – 32.5) |
Nevada |
108 |
32.4 |
6.8 |
(19.1 – 45.7) |
114 |
30.3 |
6.3 |
(18.0 – 42.6) |
New Hampshire |
209 |
35.7 |
5.0 |
(25.9 – 45.5) |
215 |
33.5 |
4.8 |
(24.1 – 42.9) |
New Jersey |
418 |
24.7 |
3.0 |
(18.8 – 30.6) |
446 |
24.6 |
2.9 |
(18.9 – 30.3) |
New Mexico |
261 |
24.4 |
4.1 |
(16.4 – 32.4) |
277 |
25.0 |
4.0 |
(17.2 – 32.8) |
New York |
216 |
38.0 |
4.6 |
(29.0 – 47.0) |
239 |
37.1 |
4.5 |
(28.3 – 45.9) |
Ohio |
388 |
25.4 |
3.1 |
(19.3 – 31.5) |
426 |
22.6 |
2.8 |
(17.1 – 28.1) |
Oregon |
193 |
39.9 |
5.0 |
(30.1 – 49.7) |
217 |
36.6 |
4.7 |
(27.4 – 45.8) |
Pennsylvania |
206 |
25.0 |
4.3 |
(16.6 – 33.4) |
225 |
24.6 |
4.0 |
(16.8 – 32.4) |
Rhode Island |
203 |
40.1 |
5.5 |
(29.3 – 50.9) |
219 |
43.1 |
5.5 |
(32.3 – 53.9) |
Texas |
367 |
33.5 |
5.0 |
(23.7 – 43.3) |
421 |
32.6 |
4.6 |
(23.6 – 41.6) |
Utah |
371 |
29.6 |
3.1 |
(23.5 – 35.7) |
401 |
27.7 |
2.9 |
(22.0 – 33.4) |
Vermont |
249 |
34.1 |
3.8 |
(26.7 – 41.5) |
254 |
36.6 |
3.9 |
(29.0 – 44.2) |
Wisconsin |
282 |
40.3 |
4.5 |
(31.5 – 49.1) |
291 |
37.4 |
4.4 |
(28.8 – 46.0) |
Puerto Rico |
293 |
22.6 |
2.7 |
(17.3 – 27.9) |
328 |
25.7 |
2.8 |
(20.2 – 31.2) |
29 states / area |
8,140 |
33.0 |
1.1 |
(30.8 – 35.2) |
8,730 |
31.7 |
1.1 |
(29.5 – 33.9) |
Median |
|
33.5 |
|
|
|
31.8 |
|
|
Range |
|
22.6-48.7 |
|
|
|
22.6-47.7 |
|
|
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval